Patient
SITE002-0018
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE002 (USA) (Dr. Nolan)
consented 2025-09-12
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
moderate
assessed
2026-06-15
Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-12-09 (study day 262); relationship: not assessed
mild
assessed
2026-05-19
Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-11-12 (study day 235); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.